Author

Ankur Sharma

BioqualPrimary ORCID profile (0000-0002-6862-136X · 6 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Ankur SharmaiD6 papers · Agency for Science, Technology and Research

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:non-human primate· 1 Assay:proteomics· 1

Frequent Co-Authors

Adian Valdez· 1 shared Albert J. Seo· 1 shared Alexandra C. WallsiD· 1 shared Alexandra SchäferiD· 1 shared Amin AddetiaiD· 1 shared Anthony CookiD· 1 shared Ashley Taylor· 1 shared Benjamin Merz· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Adian Valdez

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Phylogeny-driven design of broadly protective sarbecovirus receptor-binding domain nanoparticle vaccines

Amin Addetia, Alexandra Schäfer, Kaitlin R. Sprouse, Adian Valdez, Ashley Taylor, Mary-Jane Navarro, Jack T Brown, Elizabeth M. Leaf, Marcos C. Miranda, Alexandra C. Walls, Jimin Lee, Nicholas Catanzaro, Catherine Treichel, Isabelle Willoughby, John Powers, , David Veesler

This paper designs multivalent RBD nanoparticle vaccines that overcome immune imprinting and provide broad protection against SARS-CoV-2 variants and sarbecoviruses.

bioRxiv · May 11, 2025 · PreprintImmunology